ENTRADA THERAPEUTICS INC's ticker is and the CUSIP is 29384C108. A total of 48 filers reported holding ENTRADA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $6,930,372 | +14.3% | 438,581 | +9.5% | 0.00% | 0.0% |
Q2 2023 | $6,065,553 | +127.6% | 400,631 | +118.0% | 0.00% | – |
Q1 2023 | $2,664,955 | +108231.5% | 183,790 | +1.0% | 0.00% | – |
Q4 2022 | $2,460 | -99.9% | 181,957 | +8.9% | 0.00% | – |
Q3 2022 | $2,633,000 | +112.5% | 167,118 | +64.2% | 0.00% | – |
Q2 2022 | $1,239,000 | -25.7% | 101,771 | -42.7% | 0.00% | – |
Q1 2022 | $1,668,000 | -39.9% | 177,733 | +9.6% | 0.00% | – |
Q4 2021 | $2,776,000 | – | 162,187 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
72 Investment Holdings, LLC | 509,023 | $7,706,608 | 60.04% |
MPM ASSET MANAGEMENT LLC | 4,425,784 | $67,006,370 | 32.86% |
5AM Venture Management, LLC | 4,408,379 | $66,742,858 | 16.63% |
StepStone Group LP | 761,277 | $11,525,734 | 2.13% |
TCG Crossover Management, LLC | 584,955 | $8,856,219 | 1.45% |
Redmile Group, LLC | 1,311,572 | $19,857,200 | 0.76% |
Nan Fung Group Holdings Ltd | 49,082 | $743,101 | 0.48% |
Baker Brothers Advisors | 4,865,819 | $73,668,500 | 0.43% |
Corton Capital Inc. | 18,067 | $273,534 | 0.13% |
MOORE CAPITAL MANAGEMENT, LP | 105,000 | $1,589,700 | 0.03% |